NVRO - Nevro Corp.

NYSE - NYSE Delayed Price. Currency in USD

Nevro Corp.

1800 Bridge Parkway
Redwood City, CA 94065
United States

IndustryMedical Appliances & Equipment
Full Time Employees804

Key Executives

NameTitlePayExercisedYear Born
Mr. Patrick SchmitzVP of Operations466.66kN/A1960
Mr. Kashif RashidGen. Counsel, Corp. Sec. & Chief Compliance Officer502.18kN/A1974
Mr. Doug AlleavitchVP of Quality466.66k14.16k1961
Mr. D. Keith GrossmanChairman, CEO & PresN/AN/A1960
Ms. Juliet CunninghamVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

Corporate Governance

Nevro Corp.’s ISS Governance QualityScore as of October 4, 2019 is 7. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.